Straumann Holding Value Chain Analysis

Straumann Holding Value Chain Analysis

Fully Editable

Tailor To Your Needs In Excel Or Sheets

Professional Design

Trusted, Industry-Standard Templates

Pre-Built

For Quick And Efficient Use

No Expertise Is Needed

Easy To Follow

Straumann Holding Bundle

Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
Icon

Go Beyond the Preview – Access the Full Value Chain Analysis

This Straumann Holding Value Chain Analysis helps you understand how the company creates value across support and primary activities in one clear framework. This page already shows a real preview of the actual report content, so you can review the style and substance before buying. Purchase the full version to get the complete ready-to-use analysis instantly.

Support Activities

Icon

Firm Infrastructure

Straumann Holding AG's firm infrastructure is anchored in a Swiss headquarters model that keeps governance, pricing control, and compliance tight across a medtech group serving dental markets in over 100 countries. In 2025, that structure helps it manage product approvals, quality systems, and reimbursement rules with less drift between regions. One line: in implants and clear aligners, slow compliance means lost sales.

Icon

Human Resource Management

Straumann Holding AG's Human Resource Management hires dentists, engineers, software staff, factory teams, and clinical trainers, which fits a business that depends on clinician trust and precise execution. In its 2025 fiscal year, that skill mix supports a business that generated around CHF 2.5 billion in revenue and served more than 100 markets. Strong hiring, training, and sales education help Straumann Holding AG protect product quality and speed adoption of its implant and digital dentistry systems.

Explore a Preview
Icon

Technology Development

Straumann Holding AG keeps investing in implants, biomaterials, intraoral scanners, software, and clear aligner workflows, so the same digital thread can run from planning to restorative care. That matters because its 2025 business sits in a market of CHF 2.5 billion-plus annual sales scale, where better interoperability can lift adoption and defend share. This support activity helps Straumann Holding AG tie hardware, software, and treatment workflow into one system.

Icon

Procurement

Straumann Holding AG sources titanium, biomaterials, electronics, and precision parts from qualified suppliers to keep implant quality tight and delivery steady. In 2025, this matters even more in a regulated market: strong supplier checks protect traceability, cut defects, and lower the risk of batch delays. For dental devices, procurement is not just buying; it is a control point for safety and consistency.

Icon
Icon

Straumann's 2025 Backbone: Governance, Talent, R&D, Supply

Straumann Holding AG's support activities in 2025 focused on tight governance, talent, R&D, and supplier control across a business with about CHF 2.5 billion in revenue and sales in 100+ markets. Its Swiss-led infrastructure supports approvals, pricing, and compliance. Hiring clinicians, engineers, and digital staff helps scale implants and aligners. Procurement of titanium, biomaterials, and electronics protects traceability and product quality.

Support activity 2025 signal
Infrastructure Swiss HQ, 100+ markets
HR Clinicians, engineers, digital staff
R&D Implants, scanners, aligners
Procurement Titanium, biomaterials, electronics

What is included in the product

Word Icon Detailed Word Document
Analyzes Straumann Holding's business model through the main components of the value chain framework
Plus Icon
Excel Icon Editable Excel File
Provides a concise Straumann Holding value chain snapshot for quickly spotting operational pain points, support activities, and value drivers.

Primary Activities

Icon

Inbound Logistics

Straumann Holding AG sources titanium, polymers, biomaterials, scanner parts, and packaging under strict lot-level traceability, so every input can be traced from supplier to final device. Incoming inspection screens for dimensional, chemical, and contamination defects before precision manufacturing starts, which helps protect yield and patient safety. In 2025, that control matters because dental implant and digital workflow parts need very tight tolerances, and even small input errors can trigger costly rework and delays.

Icon

Operations

In 2025, Straumann Holding AG turned precision manufacturing into value by making implants, prosthetics, biomaterials, scanners, and aligners under tight quality checks. That matters because premium oral care is won on fit, safety, and regulatory compliance, not volume alone. With 2025 sales near CHF 2.5 billion, operations stayed central to converting product performance into pricing power.

Explore a Preview
Icon

Outbound Logistics

Straumann Holding AG ships finished implants, prosthetics, and digital products through regional hubs, direct sales, and local partners, so dental professionals get supply where treatment happens.

Efficient inventory placement and fast fulfillment cut lead times for time-sensitive clinical procedures, which matters because implant cases often depend on exact delivery dates. That setup also helps Straumann Holding AG keep service levels high while managing cross-border distribution.

Icon

Marketing and Sales

Straumann Holding AG's marketing and sales rely on field teams, distributors, clinical education, and digital engagement, not mass-market ads. This suits a high-trust model in which dentists and clinics want proof before they buy.

The sales pitch centers on workflow value across implants, digital tools, and orthodontic solutions, so reps must show clinical and economic gains, not just product features. That makes education, demos, and local support core to demand creation.

Icon

Service

Straumann Holding AG backs clinics after the sale with technical service, training, case planning, and software help. That support cuts setup friction, speeds adoption, and helps keep clinics on Straumann Holding AG systems. In 2025, with sales of about CHF 2.5 billion, that service layer mattered for repeat use and long-term customer ties.

Icon

Straumann's 2025 Growth Engine: Precision, Reach, and Repeat Use

Straumann Holding AG's primary activities in 2025 covered precision manufacturing, global distribution, sales, and post-sale support for implants, prosthetics, biomaterials, scanners, and aligners. With 2025 sales near CHF 2.5 billion, each step had to protect fit, traceability, and clinic uptime. The group's direct sales, local partners, and training services helped turn product quality into repeat use.

2025 metric Value
Sales ~CHF 2.5 billion

Preview the Actual Deliverable
Straumann Holding Reference Sources

This is the actual Straumann Holding Value Chain Analysis document you'll receive after purchase – no surprises, just the full professional version. The preview below is taken directly from the final report, so what you see is what you get. Unlock the complete, detailed Value Chain Analysis instantly after checkout.

Explore a Preview

Frequently Asked Questions

Firm infrastructure and clinical education support Straumann Holding AG Value Chain Analysis most. The business serves regulated dental markets in 100+ countries, so compliance, quality systems, and regional coordination are critical. Its portfolio spans implants, prosthetics, biomaterials, scanners, software, and clear aligners, which makes shared governance and common standards across 3 customer groups a meaningful scale advantage.

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.